Marta E Alarcón-Riquelme Selected Research

Marta E Alarcón-Riquelme Research Topics

Disease

41	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2023 - 01/2004
29	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 01/2004
10	Inflammation (Inflammations) 01/2023 - 08/2004
9	Rheumatoid Arthritis 06/2023 - 01/2004
5	Lupus Nephritis 12/2023 - 04/2009
5	Systemic Scleroderma (Systemic Sclerosis) 06/2023 - 02/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 01/2004
4	COVID-19 01/2022 - 10/2020
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2013 - 01/2004
3	Disease Susceptibility (Diathesis) 01/2017 - 07/2012
3	Arthritis (Polyarthritis) 02/2011 - 10/2005
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2023 - 08/2009
2	Oral Ulcer (Mouth Ulcer) 10/2011 - 02/2011
2	malar rash 10/2011 - 01/2011
1	Pregnancy Complications 12/2023
1	Rheumatic Diseases (Rheumatism) 06/2023
1	Vasculitis (Vasculitides) 01/2023
1	Infections 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Undifferentiated Connective Tissue Diseases 10/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2019
1	Spondyloenchondrodysplasia 01/2017
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2015
1	Glomerulonephritis 06/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Exanthema (Rash) 10/2011
1	Proteinuria 01/2011
1	Seizures (Absence Seizure) 01/2011
1	Hemolytic Anemia 01/2011
1	Dermatomyositis (Dermatopolymyositis) 01/2010
1	Thrombosis (Thrombus) 08/2009
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2009
1	Nephritis 04/2009

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 12/2023 - 08/2004
9	InterferonsIBA 06/2023 - 01/2010
8	CytokinesIBA 01/2023 - 10/2009
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2016
5	Interferon Type IIBA 01/2017 - 05/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2009
4	AntibodiesIBA 01/2016 - 10/2005
3	Nucleic AcidsIBA 02/2022 - 08/2006
3	Interleukin-2 (IL2)IBA 01/2021 - 06/2011
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2012
3	Immunoglobulin G (IgG)IBA 01/2016 - 10/2005
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
2	Antiphospholipid AntibodiesIBA 12/2023 - 08/2009
2	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2022
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 10/2022 - 01/2016
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015 - 02/2011
2	Antigen-Antibody Complex (Immune Complex)IBA 06/2015 - 08/2004
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 01/2004
2	anti-dsDNA autoantibodyIBA 03/2011 - 01/2011
2	CD11b AntigenIBA 03/2009 - 02/2008
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	Poly dA-dT (dT, Poly dA)IBA 01/2023
1	SS-A antibodiesIBA 10/2022
1	ChemokinesIBA 02/2022
1	Imiquimod (Aldara)FDA LinkGeneric 02/2022
1	voclosporinIBA 01/2022
1	anifrolumabIBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	AntigensIBA 05/2021
1	Genetic Markers (Genetic Marker)IBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	RibonucleoproteinsIBA 01/2019
1	PlasticsIBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 01/2017
1	Surface Antigens (Surface Antigen)IBA 12/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015
1	ChromatinIBA 02/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2013
1	NucleolinIBA 01/2013
1	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 01/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2012
1	SmokeIBA 06/2012
1	Silicon Dioxide (Silica)FDA LinkGeneric 06/2012
1	Hormones (Hormone)IBA 06/2012
1	AutoantigensIBA 04/2012
1	Interferon-alpha (Interferon Alfa)IBA 03/2012
1	Acid PhosphataseIBA 01/2012
1	Macrophage Migration-Inhibitory FactorsIBA 12/2011
1	Complement Factor H (Factor H)IBA 05/2011
1	Programmed Cell Death 1 ReceptorIBA 06/2010
1	interferon kappaIBA 01/2010
1	Interleukin-18 (Interleukin 18)IBA 10/2009
1	Interleukin-21 ReceptorsIBA 08/2009
1	EsterasesIBA 04/2009
1	Serine (L-Serine)FDA Link 04/2009
1	Kallikreins (Kallikrein)IBA 04/2009
1	antiglomerular basement membrane antibodyIBA 04/2009
1	Antinuclear AntibodiesIBA 12/2008
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2008

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2015
3	Precision Medicine 05/2023 - 01/2021
1	Ambulatory Care (Outpatient Care) 10/2020